Industry news
Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Company details
If you want to find out more about the company visit Lonza Group profile.
Related reports
Related news
Latest News
- OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary
- Omnicare Announces Acquisition of Continuing Care Rx
- CULS Conversion and Additional Listing
- US Educational Support Service for MS Community, MS LifeLines
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- LGC and China Association for Standardisation sign Memorandum of Understanding
- 3M to Acquire Attenti Holdings S.A.
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
- SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
- Meda acquires Alaven, a US specialty pharma company
- More news... | RSS Feed...
Most Viewed
CULS Conversion and Additional Listing
OXIS International, Inc. (OXIS) Announces the Launch of Oxis Consumer Products Subsidiary
Omnicare Announces Acquisition of Continuing Care Rx
US Educational Support Service for MS Community, MS LifeLines
Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
LGC and China Association for Standardisation sign Memorandum of Understanding
The Gamida Cell-TEVA Joint Venture Receives FDA Fast Track Designation for StemEx
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us